Biotech

All Articles

Novo inks $600M NanoVation offer to research genetic medicines ex-liver

.Novo Nordisk is proceeding its own press right into genetic medications, accepting to compensate Na...

Innovent links cytokine to intestines cancer cells reactions

.Innovent Biologics has produced the instance that its gate inhibitor-cytokine blend healthy protein...

Merck, Daiichi ADC hits objective in period 3 bronchi cancer cells study

.A phase 3 trial of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate...

Rakovina deepens AI center with collab to decide on cancer targets

.5 months after Rakovina Therapies turned toward expert system, the cancer-focused biotech has parti...

Ascendis' dwarfism drug hits in stage 3, intimidates BioMarin

.Ascendis Pharma has actually emerged as a prospective threat to BioMarin's Voxzogo, stating phase 3...

Despite ph. 3 miss out on, Alkeus observes path in advance for eye illness property

.Though Alkeus Pharmaceuticals' dental eye condition possession stopped working to dramatically mini...

Kairos goes social with $6M IPO to money tests of cancer cells medicine

.With a trio of biotechs striking the Nasdaq on Friday, it was quick and easy to miss a smaller-scal...

Vaccine and also Keytruda combination helpful in squamous tissue carcinoma

.Immune gate inhibitors are actually the superheroes of cancer therapy. Medications like Bristol Mye...

Cue Biopharma queues up J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of substantial management hirings, firings as w...

Regeneron's Opdualag rival presents 57% feedback rate

.Regeneron is back along with long-lasting consequence for its own LAG-3 inhibitor and also PD-1 pre...